T

Temmune Therapeutics (Public limited company)

BE 0776.938.722 Active ●Kardinaal Mercierplein 2, 2800 Malines

Temmune Therapeutics is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0776.938.722. It was founded on 08-11-2021. Its registered office is in Mechelen. Its main activity is: Manufacture of basic pharmaceutical products and pharmaceutical preparations. Its annual accounts for 2025 report equity of € 2 013 866 and a loss of € 2 210 492. Addrly gives it a financial health grade of D, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 4 financial years.

Information last updated on 18-10-2026.

Company information

Status
Active
Enterprise number
BE 0776.938.722
VAT registered
Yes
Founded
08-11-2021
Latest accounts
2025
Employees
-
Region
Flanders
Establishments
1
Filing record
On time 4 of 4 years
Peppol e-invoicing
Registered
Registered office
Kardinaal Mercierplein 2, 2800 Malines
Main activity
Manufacture of basic pharmaceutical products and pharmaceutical preparations
NACE activities
21201 Fabrication de médicaments
21209 Fabrication d'autres produits pharmaceutiques
72101 Recherche-développement en biotechnologie
74999 Autres activités des professions libérales et autres activités scientifiques et techniques, nca

Key figures of Temmune Therapeutics

2025202420232022
Profit / loss
iWhat the period earned after taxes. A negative amount is a loss.
€ -2 210 492-100 %€ -1 107 665-96 %€ -564 587+24 %€ -744 736
Equity
iWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company.
€ 2 013 866-9 %€ 2 224 357+2 059 %€ 103 010-55 %€ 230 264
Total assets
iEverything the company owns. Equal to total equity and liabilities, which says how it is financed.
€ 3 434 090+30 %€ 2 647 972+1 238 %€ 197 859-28 %€ 276 615
Gross margin
iSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else.
€ -377 020-17 %€ -322 150+43 %€ -560 686+24 %€ -737 436
Employees (FTE)
iAverage number of workers over the period, in full-time equivalents.
----

Financial estimate

Financial health grade D, on a scale from A (safest) to E (most at risk)
Health barometer
The failure probability and the indicators behind this grade are visible with a free account.
Create a free account
Illustrative preview
Detected events
Appointments, capital, registered office, proceedings, extracted from the official acts.
Create a free account
Illustrative preview
Directors & mandates
9 mandates on record in the annual accounts. 8 of them started since 2024.
Create a free account

Similar companies

Other companies in the same activity in Mechelen.

CompanyTown
TECHRITOR 2800 Mechelen
KOMFORM 2800 Mechelen
Invigo Therapeutics 2800 Mechelen
HFLV IR 2800 Mechelen
Looking for more information about Temmune Therapeutics?
The free plan gives you 20 complete company dossiers every month, no card required: health barometer, directors, company links and detected events.
Create a free account

Frequently asked questions

Is Temmune Therapeutics still active? Yes. The Crossroads Bank for Enterprises lists Temmune Therapeutics as active.

What is the VAT number of Temmune Therapeutics? The VAT number of Temmune Therapeutics is BE 0776.938.722.

When was Temmune Therapeutics founded? Temmune Therapeutics was founded on 08-11-2021.

What is the address of Temmune Therapeutics? The current registered office of Temmune Therapeutics is Kardinaal Mercierplein 2, 2800 Malines.

When did Temmune Therapeutics last file annual accounts? The latest annual accounts of Temmune Therapeutics were filed on 07-04-2026.

Does Temmune Therapeutics file its annual accounts on time? Yes. Temmune Therapeutics filed its annual accounts within the legal deadline for each of its last 4 financial years.

Is Temmune Therapeutics financially healthy? Addrly gives Temmune Therapeutics a financial health grade of D, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.

Is Temmune Therapeutics profitable? The annual accounts of Temmune Therapeutics for 2025 show a loss of € 2 210 492.

What is the equity of Temmune Therapeutics? The equity of Temmune Therapeutics was € 2 013 866 at the close of the 2025 financial year.

Who are the directors of Temmune Therapeutics? The annual accounts of Temmune Therapeutics record 9 mandates. The names, roles and dates are visible with a free account.

Can Temmune Therapeutics receive Peppol e-invoices? Yes. Temmune Therapeutics is registered on the Peppol network and can receive structured electronic invoices.

What does Temmune Therapeutics do? The main activity of Temmune Therapeutics is: Manufacture of basic pharmaceutical products and pharmaceutical preparations.

Sources

How Addrly builds and refreshes this data